Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications cost effectiveness model age related macular degeneration comparing macugen visudyne
… treatment and vaccine development Although COVID-19-related disruptions to the pharmaceutical supply chain and to …
… programming decision analytic economic models, including cost-effectiveness, cost-utility, cost-benefit, and budget-impact models, using …
European Society for Paediatric Infectious Diseases (ESPID) 2023 Share on: Monday, May 8 - Friday, May 12, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at ESPID 2023. Modelling the public health impact of …
Joint Clinical Assessment Support Get Ready for Your 100-Day Sprint With only 100 days between confirmation of the Population, Intervention, Comparator(s) and Outcomes (PICOs) and dossier submission, companies getting prepared now will be in the best …
… Value in Health. This webinar explores the trends in PRO-related product labeling and highlight some key observations … of successes and failures, and the lessons we've learned Related Services Market Access and Outcomes Strategy …
… P, Ren J, Schepart A, Aydin D, DeBonaventura M. Health-related quality of life (HRQOL) in patients (pts) with … J, Kondo K, Moehler MH. Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung …
Market Access and Evidence Generation Strategies At every stage of your product’s lifecycle, we can help you develop a strategic roadmap to effectively demonstrate and communicate your product’s value . For clinical and commercial teams alike, we provide …
… is launched Ensuring patients can trust the safety and effectiveness of their medicines is at the center of EMA’s … (UMCU), Netherlands Utrecht University (UU), Netherlands Related Services Pharmacoepidemiology and Risk Management …
… variations into economic evaluation, using distributional cost-effectiveness analysis. She also has experience in clinical …
JCA Strategy and Planning The launch of Joint Clinical Assessments in 2025 represents a significant change to the marketing authorization process in the EU. It is critical that drug and device developers become informed on the latest guidance to be …